Serum Level of Calpains Product as a Novel Biomarker of Acute Lung Injury Following Cardiopulmonary Bypass

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Lung Injury, Acute
Interventions
DIAGNOSTIC_TEST

blood cell analysis, blood gas surveillance, chest radiograph and echocardiography

Laboratory parameters of all postoperative patients including blood cell analysis, blood gas surveillance, liver, and kidney function alone with chest radiograph and echocardiography were dynamically monitored.

Trial Locations (1)

225000

the Affiliated Hospital of Yangzhou University, Yangzhou

All Listed Sponsors
lead

Yangzhou University

OTHER